Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction
Morten Schou, Mark C. Petrie, Barry A. Borlaug, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 3, pp. 247-257
Open Access | Times Cited: 19

Showing 19 citing articles:

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Mikhail Kosiborod, John Deanfield, Richard Pratley, et al.
The Lancet (2024) Vol. 404, Iss. 10456, pp. 949-961
Closed Access | Times Cited: 49
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?
Paschalis Karakasis, Nikolaos Fragakis, Dimitrios Patoulias, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2112-2112
Open Access | Times Cited: 14
Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction
Subodh Verma, Javed Butler, Barry A. Borlaug, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1603-1614
Open Access | Times Cited: 12
Clinical Update in Heart Failure with Preserved Ejection Fraction
Chayakrit Krittanawong, William Britt, Affan Rizwan, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 5, pp. 461-484
Closed Access | Times Cited: 4
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults
Ashkan Hashemi, Min Ji Kwak, Parag Goyal
Drugs & Aging (2025)
Closed Access
Advances in the management of obesity and heart failure: latest evidence from clinical trials
Thomaz Alexandre Costa, Josephine Harrington
Current Opinion in Cardiology (2025)
Closed Access
Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
Celestine I. Odigwe, Rajasekhar Mulyala, H. A. Malik, et al.
American Heart Journal Plus Cardiology Research and Practice (2025) Vol. 52, pp. 100518-100518
Open Access
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
Labib Imran Faruque, Kevin Yau, David Z.I. Cherney
Current Opinion in Nephrology & Hypertension (2025)
Closed Access
Holistic View of Tirzepatide’s Role in Obesity-Related HFpEF
Neha J. Pagidipati
Circulation (2025) Vol. 151, Iss. 10, pp. 669-671
Closed Access
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
Richard Salvador, Carla Moutinho, Carla Silva, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 399-399
Open Access
Development and validation of an integrated prognostic model for all-cause mortality in heart failure: a comprehensive analysis combining clinical, electrocardiographic, and echocardiographic parameters
Yahui Li, Jiayu Xu, Xuhui Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Semaglutide in heart failure and atherosclerotic cardiovascular disease: the current state-of-the-art
Nikolaos Theodorakis, Magdalini Kreouzi, Maria Nikolaou
Heart Failure Reviews (2025)
Closed Access
Preprocedure Care of Patients on Glucagon-like Peptide-1 Receptor Agonists: A Multisociety Clinical Practice Guidance
Girish P. Joshi, Teresa LaMasters, Tammy L. Kindel
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1208-1209
Open Access | Times Cited: 3
Heart Failure With Preserved Ejection Fraction
Antonio Cannatà, Daniel I. Bromage, Susan Piper, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 3, pp. 258-259
Closed Access | Times Cited: 2
STEP-HF: Reduktion Übergewicht verbessert NYHA-Klasse, Symptome und Surrogatparameter (CRP, NT-ProBNP) bei HFpEF

Aktuelle Kardiologie (2024) Vol. 13, Iss. 05, pp. 350-352
Closed Access
Impact of semaglutide on weight and functional outcomes among obese heart failure patients: a propensity scores matching analysis
Mahmoud Balata, Marc Ulrich Becher
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Preoperative Strategies for Patients on Glucagon-like Peptide-1 Receptor Agonists Navigating Current Controversies and Future Directions
Girish P. Joshi
Anesthesiology (2024) Vol. 141, Iss. 6, pp. 1031-1033
Closed Access
Safety and Efficacy of GLP-1 Agonists in a Cohort of Patients with Fontan Circulation
Andrew M. Freddo, Humera Ahmed, Jonathan B. Edelson, et al.
Pediatric Cardiology (2024)
Open Access
Obesity, Metabolic Syndrome, and Obesity Paradox in Heart Failure: A Critical Evaluation
Vince Catalfamo, Austin W. Tutor, Adrienne Koos, et al.
Current Heart Failure Reports (2024) Vol. 22, Iss. 1
Closed Access
Page 1

Scroll to top